MrPink VC

MrPink VC is an early-stage venture firm with a memorable brand and a public footprint that suggests a small, founder-friendly seed investor, plausibly with Spanish, Southern European, or US connections. Without disclosed thesis, stage, or check-size data, founders should anchor expectations to typical emerging-manager norms. Healthcare exposure is unstated and almost certainly opportunistic rather than thematic; expect openness to digital health and AI-native health categories where the company is fundamentally a software business with strong scaling potential, but limited specialist clinical or regulatory diligence capacity. AI focus is plausibly real given the broader emerging-manager pattern. Without disclosed data, expect pre-seed and seed checks plausibly in the EUR 100K to EUR 500K range, often co-investing alongside other small European or US seed funds. This is the wrong door for therapeutics, devices, or care-delivery businesses that need deep healthcare-specialist capital. It is a plausible co-investor for early healthcare software founders who already have a healthcare-credible lead and want additional founder-friendly seed capital on the cap table. Entry path is the website and direct LinkedIn outreach to whoever surfaces as the principal; warm introductions from the European seed ecosystem are by far the most reliable channel. Founders should be candid about whether the firm’s generalist orientation truly serves their go-to-market path before committing significant time to the conversation.